| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0360-3016(02)04151-2 |
| P698 | PubMed publication ID | 12573764 |
| P50 | author | Ritsuko Komaki | Q64585410 |
| Ara A Vaporciyan | Q107455112 | ||
| P2093 | author name string | Craig W Stevens | |
| Zhongxing Liao | |||
| George Starkschall | |||
| W Roy Smythe | |||
| Anesa Ahamad | |||
| Kenneth M Forster | |||
| Jason F Kelly | |||
| P2860 | cites work | A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group | Q34295028 |
| Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients | Q34485292 | ||
| Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients | Q36437220 | ||
| Intracavitary photodynamic therapy for malignant pleural mesothelioma | Q36682738 | ||
| Patterns of failure after trimodality therapy for malignant pleural mesothelioma | Q40906267 | ||
| Analysis of current trends in United States mesothelioma incidence | Q40906672 | ||
| Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients | Q41226875 | ||
| Simian virus 40, poliovaccines and human tumors: a review of recent developments | Q41640244 | ||
| Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. | Q45752954 | ||
| Treatment of malignant mesothelioma | Q45876865 | ||
| Surgically debulked malignant pleural mesothelioma: results and prognostic factors. | Q50956871 | ||
| Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. | Q53341193 | ||
| A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. | Q53369235 | ||
| Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. | Q54765031 | ||
| Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer | Q57619699 | ||
| Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer | Q62514253 | ||
| Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985 | Q68003877 | ||
| Physical aspects of external beam radiotherapy for the treatment of malignant pleural mesothelioma | Q68342394 | ||
| Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma | Q70633771 | ||
| Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma | Q70736032 | ||
| Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma | Q71299915 | ||
| Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients | Q71545796 | ||
| Computerized tomography scanning and the planning of high-dose radiotherapy for pleural mesothelioma: a report of five patients | Q71570851 | ||
| Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study | Q72766004 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 768-775 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. | |
| P478 | volume | 55 |
| Q47327130 | Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment |
| Q35832903 | Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel approach |
| Q36162505 | Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma |
| Q38800916 | Advances in treatment of mesothelioma. |
| Q30478994 | BTS statement on malignant mesothelioma in the UK, 2007. |
| Q35686412 | Clinical use of intensity-modulated radiotherapy: part I. |
| Q83206656 | Early mesothelioma revisited |
| Q80159047 | Endoscopic ultrasound-guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma |
| Q51828450 | Evaluation of the dose calculation accuracy in intensity-modulated radiation therapy for mesothelioma, focusing on low doses to the contralateral lung. |
| Q55543834 | Evaluation of the dose calculation accuracy in intensity‐modulated radiation therapy for mesothelioma, focusing on low doses to the contralateral lung. |
| Q35960203 | External beam radiation therapy for the treatment of pleural mesothelioma |
| Q37449036 | Future developments in the management of malignant pleural mesothelioma |
| Q41035061 | Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs |
| Q48094787 | High-dose palliative radiotherapy for malignant pleural mesothelioma. |
| Q34991655 | Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim. |
| Q38809684 | Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma |
| Q51687514 | Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. |
| Q38819267 | Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma |
| Q53586030 | Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy. |
| Q34293068 | Investigational approaches for mesothelioma |
| Q38255347 | Local and systemic therapies for malignant pleural mesothelioma |
| Q33438674 | Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma |
| Q36417109 | Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy |
| Q34616102 | Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. |
| Q80961479 | Malignant mesothelioma |
| Q47098675 | Malignant mesothelioma: Canadian perspective and research directions |
| Q83412919 | Malignant pleural mesothelioma |
| Q34513958 | Malignant pleural mesothelioma: an update on diagnosis and treatment options |
| Q36728254 | Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. |
| Q37866786 | Malignant pleural mesothelioma: when is radiation therapy indicated? |
| Q33244201 | Management of malignant mesothelioma by decortication and adjunct phototherapy |
| Q35839385 | Mesothelioma: a review |
| Q38087689 | New era of radiotherapy: an update in radiation-induced lung disease. |
| Q42270461 | Novel radiation therapy approaches in malignant pleural mesothelioma |
| Q82257520 | PET-guided dose escalation tomotherapy in malignant pleural mesothelioma |
| Q41697761 | Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma |
| Q34274850 | Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma |
| Q35903121 | Pleural mesothelioma: little evidence, still time to do trials |
| Q40528888 | Practical experience with intensity-modulated radiotherapy |
| Q24245556 | Radiotherapy for malignant pleural mesothelioma |
| Q50200696 | Radiotherapy for the treatment of malignant pleural mesothelioma |
| Q37762833 | Surgery for malignant pleural mesothelioma |
| Q53184110 | Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma. |
| Q64101494 | Therapeutic efficacy evaluation of radioimmunotherapy with Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma |
| Q41220761 | Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma |
Search more.